These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2116253)

  • 1. Nonsteroidal antiinflammatory drugs (NSAID's) and the bowel mucosa: changes in intestinal permeability may not be due to changes in prostaglandins.
    Rooney PJ; Jenkins RT
    Clin Exp Rheumatol; 1990; 8(3):328-9. PubMed ID: 2116253
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental evidence of the benefit of misoprostol beyond the stomach in humans.
    Bjarnason I
    J Rheumatol Suppl; 1990 Feb; 20():38-41. PubMed ID: 2109075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of misoprostol in preventing stress-induced intestinal fluid secretion in rats.
    Empey LR; Fedorak RN
    Prostaglandins Leukot Essent Fatty Acids; 1989 Oct; 38(1):43-8. PubMed ID: 2514431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors.
    Renga B; Mencarelli A; Cipriani S; D'Amore C; Francisci D; Santucci L; Baldelli F; Distrutti E; Fiorucci S
    Eur J Pharmacol; 2014 Jan; 723():194-201. PubMed ID: 24315932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic effect of Misoprostol on gastric lesions induced by aspirin (ASA) in healthy subjects].
    Naves J; Santoyo R; Morales I
    Rev Gastroenterol Mex; 1989; 54(4):203-6. PubMed ID: 2515571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man.
    Bjarnason I; Zanelli G; Smith T; Smethurst P; Price AB; Gumpel MJ; Levi AJ
    Scand J Rheumatol Suppl; 1987; 64():55-62. PubMed ID: 3324305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa.
    Lanza F; Rack MF; Lynn M; Wolf J; Sanda M
    J Rheumatol; 1987 Apr; 14(2):338-41. PubMed ID: 2955117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin-stimulated recovery of the human duodenal epithelium: effects of misoprostol on ethanol damage.
    Foschi D; Marazzi M; Toti GL; Radaelli E; Ferrante F; Vaiani G; Galeone M; Trabucchi E
    Am J Gastroenterol; 1990 Nov; 85(11):1498-502. PubMed ID: 2122722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE
    Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS; Stead H; Wallemark CB; Nicholson PA
    J Rheumatol Suppl; 1991 Mar; 28():11-4. PubMed ID: 1903808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM; Saggioro A
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins in gastroenterology. Focus on misoprostol. Proceedings of an international symposium. Algarve, Portugal, September 13-14, 1984.
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):1S-205S. PubMed ID: 3932040
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurological adverse effects of naproxen and misoprostol combination.
    Huq M
    Br J Gen Pract; 1990 Oct; 40(339):432. PubMed ID: 2125432
    [No Abstract]   [Full Text] [Related]  

  • 15. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline E. coli bacteremia--effects of misoprostol/scavengers or methylprednisolone on hemodynamic reactions and gastrointestinal mucosal injury.
    Arvidsson S; Fält K; Haglund U
    Acta Chir Scand; 1990 Mar; 156(3):215-21. PubMed ID: 2110710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modifying effects of misoprostol and natural prostaglandins.
    Iyengar S; Contreras PC; Mick SJ; Bremer ME; McKearn JP
    Br J Rheumatol; 1991; 30 Suppl 2():71-4. PubMed ID: 1899625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
    Domschke S; Domschke W
    Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of candidates for adjunctive 'gastroprotective' prostaglandins.
    Adelizzi RA
    J Am Osteopath Assoc; 1990 Jul; 90(7):598-601. PubMed ID: 2115860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.